Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

MLA

Matthias Preusser, et al. Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2359a368325f87ec6ae4e688c9705afb&authtype=sso&custid=ns315887.

APA

Matthias Preusser, Roger Stupp, Joerg C. Tonn, David A. Reardon, Burt Nabors, Thierry Gorlia, Michael Weber, Michael Weller, & Julia Furtner. (2023). Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials.

Chicago

Matthias Preusser, Roger Stupp, Joerg C. Tonn, David A. Reardon, Burt Nabors, Thierry Gorlia, Michael Weber, Michael Weller, and Julia Furtner. 2023. “Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2359a368325f87ec6ae4e688c9705afb&authtype=sso&custid=ns315887.